))
#143 (March 06, 2024) 'Principle Trial Review and Open Q&A': FLCCC Weekly Update
Manage episode 406394101 series 3514482
Content provided by by the FLCCC Alliance and By the FLCCC Alliance. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by by the FLCCC Alliance and By the FLCCC Alliance or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this FLCCC Weekly Update, Dr. Pierre Kory was scheduled to talk with Andrew Bridgen to discuss the issue of excess deaths. The conversation had to be delayed, but there was no shortage of intrigue. Instead, Dr. Kory took us through the results of the conspicuously low-profile publication of the seventh major study on ivermectin. It was a study they designed to fail, but still showed positive results. Join us for a curious look into the latest ivermectin takedown.
Formed by leading critical care specialists in March 2020, the Front Line COVID-19 Critical Care Alliance (FLCCC) has developed highly effective treatment protocols that aim to prevent and treat COVID-19 at all stages of the disease.
We are a 100% donor-supported 501(c)(3) non-profit organization — our work would not be possible without you.
Your gifts help us expand our reach and share the latest research available, for the health and well-being of all.
To donate online, click here:
https://covid19criticalcare.com/network-support/support-our-work/
To follow FLCCC, click here:
https://covid19criticalcare.com/follow-flccc-2/
To learn more about our protocols, click here
https://covid19criticalcare.com/covid-19-protocols/
To register for weekly webinars, click here:
https://geni.us/FLCCC_Webinar_Register
To buy FLCCC gear, click here:
https://supportflccc.store/
290 episodes
Share
